Skip to main content
OpenTrials
Completed

NCT Number: NCT07695051

Effect of Cold Shower Therapy on Hot Flashes And Night Sweats in Menopausal Women

This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. The primary outcome is the change in the frequency and severity of hot flashes and night sweats after the 6-week intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Buyukada Central Family Health Center, Unit 001

Istanbul, Turkey (Türkiye)

About this study

Menopausal hot flashes and night sweats are common vasomotor symptoms that negatively affect quality of life. This randomized controlled trial investigates the effectiveness of a 6-week cold shower therapy as a non-pharmacological intervention for reducing these symptoms. Eligible menopausal women will be randomly assigned to an intervention group or a control group. The intervention group will receive cold shower therapy for six weeks, while the control group will receive routine care. Outcomes will be assessed before and after the intervention using validated measurement tools. The study aims to determine whether cold shower therapy is an effective, safe, and low-cost method for managing menopausal vasomotor symptoms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to read, write, and understand the study procedures.
  • Women aged 40-65 years.
  • Postmenopausal women experiencing hot flashes and/or night sweats.
  • Not receiving hormone replacement therapy (HRT) for vasomotor symptoms.
  • No known medical contraindication to cold shower therapy.
  • Willing to participate and able to provide written informed consent.

Exclusion criteria

  • History of serious chronic diseases that may affect hemodynamic stability (e.g., cardiovascular disease, uncontrolled hypertension, renal failure, or liver failure).
  • Current use of antidepressant or antipsychotic medications, or diagnosis of a severe psychiatric disorder.
  • Regular use of cold shower or cold-water therapy before enrollment.
  • Incomplete completion of study questionnaires or data collection forms

Treatment and study plan

Cold Shower Therapy

Behavioral

Participants in the intervention group received daily cold shower therapy for 6 weeks. Water temperature was maintained at 15-20°C using a thermometer provided to participants. The control group received routine care without cold shower therapy. Outcomes were assessed at baseline and after 6 weeks.

Primary outcomes

  1. Change in Hot Flash and Night Sweat Frequency and Severity

    Time frame: Baseline, Week 3, Week 6

    Change in the frequency and severity of hot flashes and night sweats measured at baseline, week 3 and week 6.

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.